TMEM256-PLSCR3

Chr 17

TMEM256-PLSCR3 readthrough (NMD candidate)

Also known as: C17orf61-PLSCR3

This locus represents naturally occurring read-through transcription between the neighboring chromosome 17 open reading frame 61 (C17orf61) and phospholipid scramblase 3 (PLSCR3) genes. The read-through transcript is a candidate for nonsense-mediated mRNA decay (NMD), and is unlikely to produce a protein product. [provided by RefSeq, Jan 2011]

ResearchGenerating clinical summary…
Clinical SummaryTMEM256-PLSCR3
📋
ClinVar Variants
1 unique Pathogenic / Likely Pathogenic· 24 VUS of 30 total submissions

Population Genetics & Constraint

Constraint data not available from gnomAD.

ClinVar Variant Classifications

30 submitted variants in ClinVar

Classification Summary

Likely Pathogenic1
VUS24
Likely Benign2
Benign1
1
Likely Pathogenic
24
VUS
2
Likely Benign
1
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
0
0
0
Likely Pathogenic
1
0
0
0
1
VUS
0
24
0
0
24
Likely Benign
0
2
0
0
2
Benign
0
0
0
1
1
Total1260128

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

9 pathogenic / likely-pathogenic (of 10) ClinVar copy-number / structural variants overlap TMEM256-PLSCR3 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

TMEM256-PLSCR3 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →